Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wanqi Zhu

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Cancer Management and Research|March 17, 2025
Prognostic Value of Ferroptosis-Immunity-Related Signature Genes in Cervical Cancer Radiotherapy Resistance and Risk ModelingXianzhen Zhang, Aihua Li, Wanqi Zhu, et al.
Journal of Medicinal Food|November 21, 2019
Phase II Trial of Epigallocatechin-3-Gallate in Acute Radiation-Induced Esophagitis for Esophagus CancerXiaoling Li, Ligang Xing, Yujun Zhang, et al.
Oncotarget|May 26, 2016
Epigallocatechin-3-gallate ameliorates radiation-induced acute skin damage in breast cancer patients undergoing adjuvant radiotherapyWanqi Zhu, Li Jia, Guanxuan Chen, et al.
Journal of Magnetic Resonance Imaging : JMRI|February 27, 2016
MRI In rectal cancer: Correlations between MRI features and molecular markers Ki-67, HIF-1α, and VEGFXiangjiao Meng, Huijuan Li, Lingling Kong, et al.
Journal of Cancer|November 22, 2017
Correlation of cancer stem cell markers and immune cell markers in resected non-small cell lung cancerZhaoqin Huang, Haining Yu, Jianbo Zhang, et al.
Oncotarget|January 26, 2017
The impact of intratumoral metabolic heterogeneity on postoperative recurrence and survival in resectable esophageal squamous cell carcinomaXinzhe Dong, Xiaorong Sun, Xianguang Zhao, et al.
Medicine|December 4, 2015
Expression of Human Epidermal Growth Factor Receptor-2 in Resected Rectal CancerXiangjiao Meng, Zhaoqin Huang, Jian Di, et al.
The British Journal of Radiology|November 27, 2015
Phase I study of topical epigallocatechin-3-gallate (EGCG) in patients with breast cancer receiving adjuvant radiotherapyHanxi Zhao, Wanqi Zhu, Li Jia, et al.
Scientific Reports|August 24, 2023
Efficacy and safety of epigallocatechin-3-gallate in treatment acute severe dermatitis in patients with cancer receiving radiotherapy: a phase I clinical trialJingjing Xie, Li Jia, Peng Xie, et al.
BMC Bioinformatics|April 19, 2015
Systematic computation with functional gene-sets among leukemic and hematopoietic stem cells reveals a favorable prognostic signature for acute myeloid leukemiaXinan Holly Yang, Meiyi Li, Bin Wang, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Cancer Management and Research|March 17, 2025
Prognostic Value of Ferroptosis-Immunity-Related Signature Genes in Cervical Cancer Radiotherapy Resistance and Risk ModelingXianzhen Zhang, Aihua Li, Wanqi Zhu, et al.
Journal of Medicinal Food|November 21, 2019
Phase II Trial of Epigallocatechin-3-Gallate in Acute Radiation-Induced Esophagitis for Esophagus CancerXiaoling Li, Ligang Xing, Yujun Zhang, et al.
Oncotarget|May 26, 2016
Epigallocatechin-3-gallate ameliorates radiation-induced acute skin damage in breast cancer patients undergoing adjuvant radiotherapyWanqi Zhu, Li Jia, Guanxuan Chen, et al.
Journal of Magnetic Resonance Imaging : JMRI|February 27, 2016
MRI In rectal cancer: Correlations between MRI features and molecular markers Ki-67, HIF-1α, and VEGFXiangjiao Meng, Huijuan Li, Lingling Kong, et al.
Journal of Cancer|November 22, 2017
Correlation of cancer stem cell markers and immune cell markers in resected non-small cell lung cancerZhaoqin Huang, Haining Yu, Jianbo Zhang, et al.
Oncotarget|January 26, 2017
The impact of intratumoral metabolic heterogeneity on postoperative recurrence and survival in resectable esophageal squamous cell carcinomaXinzhe Dong, Xiaorong Sun, Xianguang Zhao, et al.
Medicine|December 4, 2015
Expression of Human Epidermal Growth Factor Receptor-2 in Resected Rectal CancerXiangjiao Meng, Zhaoqin Huang, Jian Di, et al.
The British Journal of Radiology|November 27, 2015
Phase I study of topical epigallocatechin-3-gallate (EGCG) in patients with breast cancer receiving adjuvant radiotherapyHanxi Zhao, Wanqi Zhu, Li Jia, et al.
Scientific Reports|August 24, 2023
Efficacy and safety of epigallocatechin-3-gallate in treatment acute severe dermatitis in patients with cancer receiving radiotherapy: a phase I clinical trialJingjing Xie, Li Jia, Peng Xie, et al.
BMC Bioinformatics|April 19, 2015
Systematic computation with functional gene-sets among leukemic and hematopoietic stem cells reveals a favorable prognostic signature for acute myeloid leukemiaXinan Holly Yang, Meiyi Li, Bin Wang, et al.
Pageof 4